Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy
Metastatic melanoma accounts for the highest number of skin cancer-related deaths. Traditional treatments are ineffective due to their inability to induce tumor regression at a high rate. Newer treatments such as immune checkpoint inhibitors (ICI), targeted therapy (BRAFi and MEKi), and T cell recep...
Guardado en:
Autor principal: | Ali R. Jazirehi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08d8d2464a0546888f21b6f041850536 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Entendiendo las terapias actuales en melanoma metastásico
por: Rodríguez,Rocío, et al.
Publicado: (2016) -
Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models
por: Mario Sechi, et al.
Publicado: (2018) -
Journal of molecular signaling
Publicado: (2006) -
New insights to the functional role of the T cell-Antigen Presenting Cell immunological synapse
por: FAROUDI,MUSTAPHA, et al.
Publicado: (2002) -
Viral Suppression of RIPK1-Mediated Signaling
por: Darshika J. Udawatte, et al.
Publicado: (2021)